533543 Stock Overview
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Brooks Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹106.79 |
| 52 Week High | ₹185.15 |
| 52 Week Low | ₹57.05 |
| Beta | 1.38 |
| 1 Month Change | 10.09% |
| 3 Month Change | -28.74% |
| 1 Year Change | 68.44% |
| 3 Year Change | 32.33% |
| 5 Year Change | 102.25% |
| Change since IPO | 77.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| 533543 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | 6.1% | 0.7% | 1.8% |
| 1Y | 68.4% | 18.5% | 46.4% |
Return vs Industry: 533543 exceeded the Indian Life Sciences industry which returned 18.5% over the past year.
Return vs Market: 533543 exceeded the Indian Market which returned 46.4% over the past year.
Price Volatility
| 533543 volatility | |
|---|---|
| 533543 Average Weekly Movement | 8.2% |
| Life Sciences Industry Average Movement | 6.1% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 533543's share price has been volatile over the past 3 months.
Volatility Over Time: 533543's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 296 | n/a | www.brookslabs.net |
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. It offers liquid and dry powder injection, carbapenem drugs, tablets, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Brooks Laboratories Limited Fundamentals Summary
| 533543 fundamental statistics | |
|---|---|
| Market cap | ₹2.75b |
| Earnings (TTM) | -₹142.85m |
| Revenue (TTM) | ₹744.61m |
3.8x
P/S Ratio-19.6x
P/E RatioIs 533543 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 533543 income statement (TTM) | |
|---|---|
| Revenue | ₹744.61m |
| Cost of Revenue | ₹539.12m |
| Gross Profit | ₹205.50m |
| Other Expenses | ₹348.34m |
| Earnings | -₹142.85m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.44 |
| Gross Margin | 27.60% |
| Net Profit Margin | -19.18% |
| Debt/Equity Ratio | 5.3% |
How did 533543 perform over the long term?
See historical performance and comparison